N-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine

C122H118BrN35O5 — CID 157254220

IUPACN-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine
SMILESBrc1ncn(-c2ccc(Nc3nccc(-c4cccc(N5CCOCC5)c4)n3)cc2)n1.C=Cc1ncn(-c2ccc(Nc3nccc(-c4cccc(N5CCOCC5)c4)n3)cc2)n1.CCc1ncn(-c2ccc(Nc3nccc(-c4cccc(N5CCOCC5)c4)n3)cc2)n1.CCc1ncnn1-c1ccc(Nc2nccc(-c3cccc(N4CCOCC4)c3)n2)cc1.c1ccc(-c2ncn(-c3ccc(Nc4nccc(-c5cccc(N6CCOCC6)c5)n4)cc3)n2)cc1
InChIInChI=1S/C28H25N7O.C24H25N7O.C24H23N7O.C24H25N7O.C22H20BrN7O/c1-2-5-21(6-3-1)27-30-20-35(33-27)24-11-9-23(10-12-24)31-28-29-14-13-26(32-28)22-7-4-8-25(19-22)34-15-17-36-18-16-34;2*1-2-23-26-17-31(29-23)20-8-6-19(7-9-20)27-24-25-11-10-22(28-24)18-4-3-5-21(16-18)30-12-14-32-15-13-30;1-2-23-26-17-27-31(23)20-8-6-19(7-9-20)28-24-25-11-10-22(29-24)18-4-3-5-21(16-18)30-12-14-32-15-13-30;23-21-25-15-30(28-21)18-6-4-17(5-7-18)26-22-24-9-8-20(27-22)16-2-1-3-19(14-16)29-10-12-31-13-11-29/h1-14,19-20H,15-18H2,(H,29,31,32);3-11,16-17H,2,12-15H2,1H3,(H,25,27,28);2-11,16-17H,1,12-15H2,(H,25,27,28);3-11,16-17H,2,12-15H2,1H3,(H,25,28,29);1-9,14-15H,10-13H2,(H,24,26,27)
InChIKeyAWRSEUKEXBROEG-UHFFFAOYSA-N
MW2234.43 g/mol
LogP20.72
Rot. Bonds29

About N-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine

N-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine (PubChem CID 157254220) has the molecular formula C122H118BrN35O5 and a molecular weight of 2234.43 g/mol. Its IUPAC name is N-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine.

Molecular Properties

Compound NameN-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine
PubChem CID157254220
Molecular FormulaC122H118BrN35O5
Molecular Weight2234.43 g/mol
Exact Mass2231.92
IUPAC NameN-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine
SMILESBrc1ncn(-c2ccc(Nc3nccc(-c4cccc(N5CCOCC5)c4)n3)cc2)n1.C=Cc1ncn(-c2ccc(Nc3nccc(-c4cccc(N5CCOCC5)c4)n3)cc2)n1.CCc1ncn(-c2ccc(Nc3nccc(-c4cccc(N5CCOCC5)c4)n3)cc2)n1.CCc1ncnn1-c1ccc(Nc2nccc(-c3cccc(N4CCOCC4)c3)n2)cc1.c1ccc(-c2ncn(-c3ccc(Nc4nccc(-c5cccc(N6CCOCC6)c5)n4)cc3)n2)cc1
InChIInChI=1S/C28H25N7O.C24H25N7O.C24H23N7O.C24H25N7O.C22H20BrN7O/c1-2-5-21(6-3-1)27-30-20-35(33-27)24-11-9-23(10-12-24)31-28-29-14-13-26(32-28)22-7-4-8-25(19-22)34-15-17-36-18-16-34;2*1-2-23-26-17-31(29-23)20-8-6-19(7-9-20)27-24-25-11-10-22(28-24)18-4-3-5-21(16-18)30-12-14-32-15-13-30;1-2-23-26-17-27-31(23)20-8-6-19(7-9-20)28-24-25-11-10-22(29-24)18-4-3-5-21(16-18)30-12-14-32-15-13-30;23-21-25-15-30(28-21)18-6-4-17(5-7-18)26-22-24-9-8-20(27-22)16-2-1-3-19(14-16)29-10-12-31-13-11-29/h1-14,19-20H,15-18H2,(H,29,31,32);3-11,16-17H,2,12-15H2,1H3,(H,25,27,28);2-11,16-17H,1,12-15H2,(H,25,27,28);3-11,16-17H,2,12-15H2,1H3,(H,25,28,29);1-9,14-15H,10-13H2,(H,24,26,27)
InChIKeyAWRSEUKEXBROEG-UHFFFAOYSA-N
XLogP20.72
TPSA404.95 Ų
H-Bond Donors5
H-Bond Acceptors40
Rotatable Bonds29
Heavy Atoms163
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002234.43
LogP ≤ 520.72
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1040

Analyze N-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine?
The IUPAC name of N-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine (CID 157254220) is N-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine.
What is the SMILES notation for N-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine?
The canonical SMILES for N-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine is Brc1ncn(-c2ccc(Nc3nccc(-c4cccc(N5CCOCC5)c4)n3)cc2)n1.C=Cc1ncn(-c2ccc(Nc3nccc(-c4cccc(N5CCOCC5)c4)n3)cc2)n1.CCc1ncn(-c2ccc(Nc3nccc(-c4cccc(N5CCOCC5)c4)n3)cc2)n1.CCc1ncnn1-c1ccc(Nc2nccc(-c3cccc(N4CCOCC4)c3)n2)cc1.c1ccc(-c2ncn(-c3ccc(Nc4nccc(-c5cccc(N6CCOCC6)c5)n4)cc3)n2)cc1.
What is the InChIKey of N-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine?
The InChIKey is AWRSEUKEXBROEG-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H25N7O.C24H25N7O.C24H23N7O.C24H25N7O.C22H20BrN7O/c1-2-5-21(6-3-1)27-30-20-35(33-27)24-11-9-23(10-12-24)31-28-29-14-13-26(32-28)22-7-4-8-25(19-22)34-15-17-36-18-16-34;2*1-2-23-26-17-31(29-23)20-8-6-19(7-9-20)27-24-25-11-10-22(28-24)18-4-3-5-21(16-18)30-12-14-32-15-13-30;1-2-23-26-17-27-31(23)20-8-6-19(7-9-20)28-24-25-11-10-22(29-24)18-4-3-5-21(16-18)30-12-14-32-15-13-30;23-21-25-15-30(28-21)18-6-4-17(5-7-18)26-22-24-9-8-20(27-22)16-2-1-3-19(14-16)29-10-12-31-13-11-29/h1-14,19-20H,15-18H2,(H,29,31,32);3-11,16-17H,2,12-15H2,1H3,(H,25,27,28);2-11,16-17H,1,12-15H2,(H,25,27,28);3-11,16-17H,2,12-15H2,1H3,(H,25,28,29);1-9,14-15H,10-13H2,(H,24,26,27).
What are the key properties of N-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine?
N-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine has a molecular weight of 2234.43 g/mol, XLogP of 20.72, 29 rotatable bonds, 5 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(3-bromo-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethenyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(3-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;N-[4-(5-ethyl-1,2,4-triazol-1-yl)phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine;4-(3-morpholin-4-ylphenyl)-N-[4-(3-phenyl-1,2,4-triazol-1-yl)phenyl]pyrimidin-2-amine is sourced from PubChem (CID 157254220), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).